- $7.30bn
- $9.70bn
- $3.37bn
- 88
- 25
- 43
- 51
Annual balance sheet for Bruker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 732 | 1,168 | 646 | 488 | 183 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 335 | 417 | 534 | 492 | 701 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,925 | 2,472 | 2,113 | 2,164 | 2,053 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 463 | 466 | 538 | 691 | 815 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,049 | 3,650 | 3,612 | 4,250 | 5,807 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 792 | 939 | 914 | 1,202 | 1,281 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,088 | 2,580 | 2,498 | 2,873 | 4,026 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 961 | 1,071 | 1,114 | 1,377 | 1,781 |
| Total Liabilities & Shareholders' Equity | 3,049 | 3,650 | 3,612 | 4,250 | 5,807 |
| Total Common Shares Outstanding |